Auclair, Daniel
Emory University · Multiple Myeloma Research Foundation
13 papers on CoChatORCID 0000-0001-5151-3058
Most cited papers
- Verified
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature
Cancer Genomics and DiagnosticsChromatin Remodeling and Cancer
Cited by 5,461
- Verified
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell
Melanoma and MAPK PathwaysCancer Genomics and Diagnostics
Cited by 2,610
- Verified
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell
Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Cited by 1,789
- Verified
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Lohr, J. G., Stojanov, P., Carter, S. L., Cruz-Gordillo, P., Lawrence, M. S., Auclair, D., Sougnez, C., Knoechel, B., Gould, J., Saksena, G., et al. (2014) · Cancer Cell
Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics
Cited by 988
- Verified
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature
Melanoma and MAPK PathwaysCancer Genomics and Diagnostics
Cited by 756
- Verified
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Pugh, T. J., Weeraratne, S. D., Archer, T. C., Pomeranz Krummel, D. A., Auclair, D., Bochicchio, J., Carneiro, M. O., Carter, S. L., Cibulskis, K., Erlich, R. L., et al. (2012) · Nature
Glioma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 750
- Verified
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Walker, B. A., Mavrommatis, K., Wardell, C. P., Ashby, T. C., Bauer, M., Davies, F. E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., et al. (2018) · Blood
Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research
Cited by 475
- Verified
High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma
Miller, A., Asmann, Y., Cattaneo, L., Braggio, E., Keats, J., Auclair, D., Lonial, S., The MMRF CoMMpass Network, Russell, S. J., & Stewart, A. K. (2017) · Blood Cancer Journal
Multiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 145
- Verified
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins
Shirasaki, R., Matthews, G. M., Gandolfi, S., de Matos Simoes, R., Buckley, D. L., Raja Vora, J., Sievers, Q. L., Brüggenthies, J. B., Dashevsky, O., Poarch, H., et al. (2021) · Cell Reports
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 123
- Verified
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
Skerget, S., Penaherrera, D., Chari, A., Jagannath, S., Siegel, D. S., Vij, R., Orloff, G., Jakubowiak, A., Niesvizky, R., Liles, D., et al. (2024) · Nature Genetics
Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment
Cited by 95
- Verified
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
Yao, L., Jayasinghe, R. G., Lee, B. H., Bhasin, S. S., Pilcher, W., Doxie, D. B., Gonzalez-Kozlova, E., Dasari, S., Fiala, M. A., Pita-Juarez, Y., et al. (2022) · Cancer Research Communications
Multiple Myeloma Research and TreatmentsSingle-cell and spatial transcriptomics
Cited by 45
- Verified
MinimuMM-seq: genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology
Dutta, A. K., Alberge, J.-B., Lightbody, E. D., Boehner, C. J., Dunford, A., Sklavenitis-Pistofidis, R., Mouhieddine, T. H., Cowan, A. N., Su, N. K., Horowitz, E. M., et al. (2023) · Cancer Discovery
Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics
Cited by 41
- Verified
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry
Du, Z., Weinhold, N., Song, G. C., Rand, K. A., Van Den Berg, D. J., Hwang, A. E., Sheng, X., Hom, V., Ailawadhi, S., Nooka, A. K., et al. (2020) · Blood Advances
Multiple Myeloma Research and TreatmentsGenetic Associations and Epidemiology
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free